JP2011527677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527677A5 JP2011527677A5 JP2011517461A JP2011517461A JP2011527677A5 JP 2011527677 A5 JP2011527677 A5 JP 2011527677A5 JP 2011517461 A JP2011517461 A JP 2011517461A JP 2011517461 A JP2011517461 A JP 2011517461A JP 2011527677 A5 JP2011527677 A5 JP 2011527677A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- halogen
- ring
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7886708P | 2008-07-08 | 2008-07-08 | |
| US61/078,867 | 2008-07-08 | ||
| PCT/US2009/048394 WO2010005783A1 (en) | 2008-07-08 | 2009-06-24 | Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011527677A JP2011527677A (ja) | 2011-11-04 |
| JP2011527677A5 true JP2011527677A5 (https=) | 2012-08-09 |
Family
ID=41090284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517461A Pending JP2011527677A (ja) | 2008-07-08 | 2009-06-24 | Ｎｈｅ−１阻害剤として有用なピロリジニル及びピペリジニル化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110118262A1 (https=) |
| EP (1) | EP2321274A1 (https=) |
| JP (1) | JP2011527677A (https=) |
| CA (1) | CA2730116A1 (https=) |
| WO (1) | WO2010005783A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5693452B2 (ja) | 2008-08-04 | 2015-04-01 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | 特定のキヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物およびそれらの使用方法 |
| MX2012008346A (es) | 2010-01-25 | 2012-11-12 | Chdi Foundation Inc | Determinados inhibidores de cinurenina-3-monooxigenasa, composiciones farmceuticas y metodos de uso de los mismos. |
| WO2011103126A1 (en) * | 2010-02-17 | 2011-08-25 | Ampla Pharmaceuticals Inc. | Treatment of metabolic syndrome with piperidine amides |
| SI2750677T1 (sl) | 2011-08-30 | 2017-10-30 | Chdi Foundation, Inc. | Inhibitorji kinurenin-3-monooksigenaze, farmacevtski sestavki in postopki njihove uporabe |
| MX2014002459A (es) | 2011-08-30 | 2014-04-10 | Chdi Foundation Inc | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos. |
| AU2013250726B2 (en) | 2012-04-20 | 2017-01-05 | Advinus Therapeutics Limited | Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof |
| FR3000065A1 (fr) | 2012-12-21 | 2014-06-27 | Univ Lille Ii Droit & Sante | Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes |
| CN104098483A (zh) * | 2013-04-12 | 2014-10-15 | 江苏英力科技发展有限公司 | 一种4-甲氧基-n,n-二甲基-1-萘甲酰胺制备方法 |
| AU2014368945C1 (en) | 2013-12-20 | 2019-05-16 | Sagimet Biosciences Inc. | Heterocyclic modulators of lipid synthesis and combinations thereof |
| CN106715421A (zh) | 2014-07-17 | 2017-05-24 | Chdi基金会股份有限公司 | 用于治疗hiv相关病症的方法和组合物 |
| WO2016028971A1 (en) | 2014-08-21 | 2016-02-25 | Bristol-Myers Squibb Company | Tied-back benzamide derivatives as potent rock inhibitors |
| EP3456716A4 (en) * | 2016-05-09 | 2019-11-06 | Nippon Soda Co., Ltd. | RINGFUL AMID CONNECTION AND PESTICIDES |
| CN106905191B (zh) * | 2017-03-05 | 2019-03-29 | 北京化工大学 | 一种含有羟肟酸基团的氮芥类化合物及其制备方法和用途 |
| JP2021515767A (ja) | 2018-03-07 | 2021-06-24 | バイエル・アクチエンゲゼルシヤフト | Ｅｒｋ５阻害剤の同定及び使用 |
| EP4628487A3 (en) | 2019-03-20 | 2025-12-24 | Emory University | Prostaglandin receptor ep2 antagonists, derivatives, and uses related thereto |
| CN113968804B (zh) * | 2020-07-22 | 2022-12-02 | 中国农业大学 | 莫奈太尔砜的半抗原、人工抗原及其制备方法与应用 |
| WO2024042160A1 (en) | 2022-08-26 | 2024-02-29 | Mitodicure Gmbh | Use of a therapeutic agent with sodium-hydrogen antiporter 1 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59305042D1 (de) * | 1992-09-22 | 1997-02-20 | Hoechst Ag | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
| US5665739A (en) * | 1992-12-15 | 1997-09-09 | Hoechst Aktiengesellschaft | Substituted benzoylguanidines, process and their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
| DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
| DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
| DE19621482A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19843489B4 (de) * | 1998-09-22 | 2006-12-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung |
| US6323207B1 (en) * | 1998-09-22 | 2001-11-27 | Boehringer Ingelheim Pharma Kg | Benzoylguanidine derivatives |
| WO2001034567A1 (en) * | 1999-11-10 | 2001-05-17 | Aventis Pharma Deutschland Gmbh | N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| DE10106970A1 (de) * | 2001-02-15 | 2002-08-29 | Boehringer Ingelheim Pharma | Neues Benzoylguanidinsalz |
| US6730678B2 (en) * | 2001-02-15 | 2004-05-04 | Boehringer Ingelheim Pharma Kg | Benzoylguanidine salt and hydrates thereof |
| US20040097583A1 (en) * | 2002-02-14 | 2004-05-20 | Hans-Jochen Lang | Use of inhibitors of the sodium/hydrogen exchanger for the treatment of thrombotic and inflammatory disorders |
| US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
| DE10353204A1 (de) * | 2003-11-13 | 2005-06-16 | Aventis Pharma Deutschland Gmbh | Verfahren zur Herstellung von 4-Pentafluorsulfanyl-benzoylguanidinen |
| US20070185152A1 (en) * | 2004-03-02 | 2007-08-09 | Smithkline Beecham Corporation | Inhibitors of akt activity |
| DE102004054847A1 (de) * | 2004-11-13 | 2006-05-24 | Sanofi-Aventis Deutschland Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| AU2006214378A1 (en) * | 2005-02-16 | 2006-08-24 | Pharmacopeia, Inc. | Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| JP2009511582A (ja) * | 2005-10-11 | 2009-03-19 | シェーリング コーポレイション | Ｃｘｃｒ３拮抗薬活性を有する置換複素環式化合物 |
-
2009
- 2009-06-24 JP JP2011517461A patent/JP2011527677A/ja active Pending
- 2009-06-24 CA CA2730116A patent/CA2730116A1/en not_active Abandoned
- 2009-06-24 WO PCT/US2009/048394 patent/WO2010005783A1/en not_active Ceased
- 2009-06-24 EP EP09789924A patent/EP2321274A1/en not_active Withdrawn
- 2009-06-24 US US13/002,658 patent/US20110118262A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011527677A5 (https=) | ||
| AU2016368317B2 (en) | Inhibitors of influenza virus replication, application methods and uses thereof | |
| CN109641868A (zh) | 流感病毒复制抑制剂及其使用方法和用途 | |
| JP2008543886A5 (https=) | ||
| JP2010513448A5 (https=) | ||
| JP2007530696A5 (https=) | ||
| JP2004503501A5 (https=) | ||
| JP2012524111A5 (https=) | ||
| HRP20171028T1 (hr) | Indolski i indazolski spojevi koji aktiviraju ampk | |
| JP2013507425A5 (https=) | ||
| JP2009263394A5 (https=) | ||
| CA2463284A1 (en) | Pyrimidine compounds and pharmaceutical compositions containing the compounds | |
| NZ592748A (en) | 2-Amino-(oxadiazol-3-yl)-benzofuran derivatives and their use as S1P receptor modulators | |
| JP2013536235A5 (https=) | ||
| JP2007513915A5 (https=) | ||
| JP2010502730A5 (https=) | ||
| AU2016372028A1 (en) | Methods of treating hyperalgesia | |
| JP2013542960A5 (https=) | ||
| CA2554049A1 (en) | Quinoline derivatives for use as mycobacterial inhibitors | |
| JP2008507539A5 (https=) | ||
| JP2015178458A (ja) | ベンゼン環縮合含窒素５員複素環式化合物、またはその薬理学的に許容される塩 | |
| RU2014115290A (ru) | Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов | |
| JP2011509301A5 (https=) | ||
| JP2011500694A5 (https=) | ||
| JP2010540666A5 (https=) |